Disease	Extramammary Paget’s disease
Stage of disease/treatment	Metastatic/advanced
Prior therapy	No designated number of regimens
Type of study	Phase II, single arm
Primary endpoint	Objective response rate after 3 cycles of treatment, safety throughout the study period
Secondary endpoints	Overall survival, progression-free survival, duration of overall response
Investigator’s analysis	Active and should be pursued further